| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Clinical Endocrinology & Metabolism, Vol 54, 1025-1027, Copyright © 1982 by Endocrine Society
ARTICLES |
H Iguchi, KI Kato and H Ibayashi
To evaluate the influence of changes in liver function on serum levels of melatonin, we measured serum levels and MCR of the hormone in patients with liver cirrhosis and in healthy control subjects. Daytime (0900-1100 h) serum levels of melatonin in patients with liver cirrhosis were significantly elevated compared to those in healthy subjects. Significant positive correlations of the daytime serum levels of melatonin with the serum retention rate of indocyanine green dye and serum levels of total bilirubin were noted. The clearance of melatonin from blood showed a biphasic first-order kinetic pattern. The half-life of each phase was significantly prolonged in patients with cirrhosis compared to healthy subjects. Our data indicate that the elevated daytime serum levels of melatonin in patients with liver cirrhosis are due to decreased clearance, probably related to decreased liver blood flow, lowered activity of 6 beta-hydroxylase, and competition with bilirubin in the intrahepatic transport system.
This article has been cited by other articles:
 |
|
 |
|
  S. L. Markantonis, E. Tsakalozou, A. Paraskeva, C. Staikou, and A. Fassoulaki Melatonin Pharmacokinetics in Premenopausal and Postmenopausal Healthy Female Volunteers J. Clin. Pharmacol., February 1, 2008; 48(2): 240 - 245. [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. M. van der Helm-van Mil, E. J. W. van Someren, R. van den Boom, M. A. van Buchem, A. J. M. de Craen, and G. J. Blauw No Influence of Melatonin on Cerebral Blood Flow in Humans J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5989 - 5994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Vijayalaxmi, C. R. Thomas Jr, R. J. Reiter, and T. S. Herman Melatonin: From Basic Research to Cancer Treatment Clinics J. Clin. Oncol., May 15, 2002; 20(10): 2575 - 2601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Fourtillan, A. M. Brisson, M. Fourtillan, I. Ingrand, J. P. Decourt, and J. Girault Melatonin secretion occurs at a constant rate in both young and older men and women Am J Physiol Endocrinol Metab, January 1, 2001; 280(1): E11 - E22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nava, F. Romero, Y. Quiroz, G. Parra, L. Bonet, and B. Rodriguez-Iturbe Melatonin attenuates acute renal failure and oxidative stress induced by mercuric chloride in rats Am J Physiol Renal Physiol, November 1, 2000; 279(5): F910 - F918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-Y. Liu, J.-N. Zhou, J. van Heerikhuize, M. A. Hofman, and D. F. Swaab Decreased Melatonin Levels in Postmortem Cerebrospinal Fluid in Relation to Aging, Alzheimer's Disease, and Apolipoprotein E-{epsilon}4/4 Genotype J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 323 - 327. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. A. Witt-Enderby, M. I. Masana, and M. L. Dubocovich Physiological Exposure to Melatonin Supersensitizes the Cyclic Adenosine 3',5'-Monophosphate-Dependent Signal Transduction Cascade in Chinese Hamster Ovary Cells Expressing the Human mt1 Melatonin Receptor Endocrinology, July 1, 1998; 139(7): 3064 - 3071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Brzezinski Melatonin in Humans N. Engl. J. Med., January 16, 1997; 336(3): 186 - 195. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
